"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 10 | 3 | 13 |
| 2005 | 7 | 2 | 9 |
| 2006 | 8 | 2 | 10 |
| 2007 | 12 | 2 | 14 |
| 2008 | 10 | 0 | 10 |
| 2009 | 11 | 3 | 14 |
| 2010 | 20 | 5 | 25 |
| 2011 | 14 | 4 | 18 |
| 2012 | 15 | 6 | 21 |
| 2013 | 19 | 4 | 23 |
| 2014 | 17 | 2 | 19 |
| 2015 | 24 | 1 | 25 |
| 2016 | 36 | 2 | 38 |
| 2017 | 33 | 2 | 35 |
| 2018 | 28 | 5 | 33 |
| 2019 | 36 | 8 | 44 |
| 2020 | 51 | 3 | 54 |
| 2021 | 52 | 4 | 56 |
| 2022 | 44 | 2 | 46 |
| 2023 | 29 | 0 | 29 |
| 2024 | 23 | 10 | 33 |
| 2025 | 49 | 0 | 49 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E. JCO Precis Oncol. 2026 Feb; 10:e2500612.
-
Use of supportive care services and advance care planning among early phase oncology clinical trial participants. Support Care Cancer. 2026 Jan 21; 34(2):112.
-
The Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research. Clin Chem. 2025 Dec 30; 72(1):82-100.
-
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers. J Immunother Cancer. 2025 Dec 21; 13(12).
-
TRAF7 in signaling and disease: emerging mechanisms and clinical implications. Mol Med. 2025 Dec 11; 32(1):4.
-
Leveraging cancer metabolism to translate into effective therapeutics. Semin Cancer Biol. 2026 Jan; 118:44-61.
-
Smartphone-Based Physical Activity Program to Reduce "Chemo-Brain" Symptoms and Improve Health in Cancer Survivors With and Without Type 2 Diabetes: Protocol for a Single-Arm Pre-Post Pilot Trial. JMIR Res Protoc. 2025 Dec 10; 14:e79739.
-
Health Outcomes in Childhood Cancer Survivors with Congenital Anomalies in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2025 Dec 01; 34(12):2228-2238.
-
Impact of infection and microbial exposures on pediatric cancer. Curr Probl Pediatr Adolesc Health Care. 2025 Sep; 55(9):101819.
-
Decision-making capacity evaluation in older cancer patients: A call to action. Palliat Support Care. 2025 Nov 14; 23:e205.